Last 12 months
Inside the activity.
0 purchase rows · 64 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 24 |
| Dec 2025 | 0 | 6 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 12 |
| Mar 2026 | 0 | 13 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 0 |
| Jun 2026 | 0 | 2 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 4 |
| Sep 2026 | 0 | 3 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| February 24, 2025 Filed Feb 26, 2025 18:54 UTC |
Davis John EChief Commercial Officer
|
SaleCommon Stock | 2,846 | $27.31 | $77,712.88 |
DisclosureSEC source: 0000784199-25-000018 · wk-form4_1740596042.xml · nonDerivative · entry 1 Davis John E · CIK 0001653206 · Chief Commercial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 164,242 F1 · shares: These shares were sold upon the vesting of restricted stock units to pay tax withholding obligations. The sale was to satisfy tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary transaction. Read SEC document |
| February 24, 2025 Filed Feb 26, 2025 18:50 UTC |
Berry Lance AExecutive VP, CFO
|
SaleCommon Stock | 3,259 | $27.31 | $88,990.25 |
DisclosureSEC source: 0000784199-25-000016 · wk-form4_1740595839.xml · nonDerivative · entry 1 Berry Lance A · CIK 0001478716 · Executive VP, CFO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 75,805 F1 · shares: These shares were sold upon the vesting of restricted stock units to pay tax withholding obligations. The sale was to satisfy tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary transaction. Read SEC document |
| February 24, 2025 Filed Feb 26, 2025 18:46 UTC |
Stanton Marshall S.SVP, Clinical & MD Affair
|
SaleCommon Stock | 1,246 | $27.31 | $34,023.28 |
DisclosureSEC source: 0000784199-25-000014 · wk-form4_1740595575.xml · nonDerivative · entry 4 Stanton Marshall S. · CIK 0001849615 · SVP, Clinical & MD Affair 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 79,845 F1 · shares: These shares were sold upon the vesting of restricted stock units to pay tax withholding obligations. The sale was to satisfy tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary transaction. Read SEC document |
| February 24, 2025 Filed Feb 26, 2025 18:46 UTC |
Stanton Marshall S.SVP, Clinical & MD Affair
|
SaleCommon Stock | 672 | $27.31 | $18,349.63 |
DisclosureSEC source: 0000784199-25-000014 · wk-form4_1740595575.xml · nonDerivative · entry 3 Stanton Marshall S. · CIK 0001849615 · SVP, Clinical & MD Affair 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 81,091 F1 · shares: These shares were sold upon the vesting of restricted stock units to pay tax withholding obligations. The sale was to satisfy tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary transaction. Read SEC document |
| February 24, 2025 Filed Feb 26, 2025 18:46 UTC |
Stanton Marshall S.SVP, Clinical & MD Affair
|
SaleCommon Stock | 470 | $27.31 | $12,833.82 |
DisclosureSEC source: 0000784199-25-000014 · wk-form4_1740595575.xml · nonDerivative · entry 2 Stanton Marshall S. · CIK 0001849615 · SVP, Clinical & MD Affair 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 81,763 F1 · shares: These shares were sold upon the vesting of restricted stock units to pay tax withholding obligations. The sale was to satisfy tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary transaction. Read SEC document |
| February 24, 2025 Filed Feb 26, 2025 18:46 UTC |
Stanton Marshall S.SVP, Clinical & MD Affair
|
SaleCommon Stock | 2,299 | $27.31 | $62,776.49 |
DisclosureSEC source: 0000784199-25-000014 · wk-form4_1740595575.xml · nonDerivative · entry 1 Stanton Marshall S. · CIK 0001849615 · SVP, Clinical & MD Affair 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 82,233 F1 · shares: These shares were sold upon the vesting of restricted stock units to pay tax withholding obligations. The sale was to satisfy tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary transaction. Read SEC document |
| December 31, 2024 Filed Jan 30, 2025 15:13 UTC |
Stanton Marshall S.SVP, Clinical & MD Affair
|
GrantCommon Stock | 381 | $21.63 | $8,241.03 |
DisclosureSEC source: 0000784199-25-000004 · wk-form5_1738249991.xml · nonDerivative · entry 2 Stanton Marshall S. · CIK 0001849615 · SVP, Clinical & MD Affair 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 84,532 F1 · price: These shares were acquired pursuant to Artivion Inc.'s Employee Stock Purchase Plan (ESPP). The shares were acquired in transactions exempt pursuant to 16b-3. Read SEC document |
| December 31, 2024 Filed Jan 30, 2025 15:09 UTC |
Holloway Jean FSVP, General Counsel
|
GrantCommon Stock | 295 | $21.63 | $6,380.85 |
DisclosureSEC source: 0000784199-25-000002 · wk-form5_1738249772.xml · nonDerivative · entry 2 Holloway Jean F · CIK 0001540065 · SVP, General Counsel 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 155,134 F1 · price: These shares were acquired pursuant to Artivion Inc.'s Employee Stock Purchase Plan (ESPP). The shares were acquired in transactions exempt pursuant to 16b-3. Read SEC document |
| December 12, 2024 Filed Dec 13, 2024 20:31 UTC |
Horton AmyVP, Chief Accounting Officer
|
GiftCommon Stock | 1,100 | $0.00 | $0.00 |
DisclosureSEC source: 0000784199-24-000262 · wk-form4_1734121861.xml · nonDerivative · entry 1 Horton Amy · CIK 0001371523 · VP, Chief Accounting Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 134,464 F1 · shares: 1,100 shares were gifted by the reporting person to a charity. Read SEC document |
| December 11, 2024 Filed Dec 12, 2024 21:11 UTC |
Holloway Jean FSVP, General Counsel
|
SaleCommon Stock | 4,035 | $30.00 | $121,050.00 |
DisclosureSEC source: 0000784199-24-000260 · wk-form4_1734037903.xml · nonDerivative · entry 2 Holloway Jean F · CIK 0001540065 · SVP, General Counsel 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 153,862 F1 · price: Reflects the price the shares were sold. Read SEC document |
| December 11, 2024 Filed Dec 12, 2024 21:11 UTC |
Holloway Jean FSVP, General Counsel
|
SaleCommon Stock | 4,035 | $30.25 | $122,058.75 |
DisclosureSEC source: 0000784199-24-000260 · wk-form4_1734037903.xml · nonDerivative · entry 1 Holloway Jean F · CIK 0001540065 · SVP, General Counsel 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 157,897 F1 · price: Reflects the price the shares were sold. Read SEC document |
| December 06, 2024 Filed Dec 9, 2024 20:34 UTC |
Horton AmyVP, Chief Accounting Officer
|
SaleCommon Stock | 4,329 | $29.66 | $128,398.14 |
DisclosureSEC source: 0000784199-24-000256 · wk-form4_1733776456.xml · nonDerivative · entry 1 Horton Amy · CIK 0001371523 · VP, Chief Accounting Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 135,660 F1 · shares: These shares were sold upon the vesting of Restricted Stock Units to pay tax withholding obligations. The sale was to satisfy tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary transaction. Read SEC document |
| December 06, 2024 Filed Dec 10, 2024 20:45 UTC Amendment |
Horton AmyVP, Chief Accounting Officer
|
SaleCommon Stock | 4,425 | $29.05 | $128,551.56 |
DisclosureSEC source: 0000784199-24-000258 · wk-form4a_1733863511.xml · nonDerivative · entry 1 Horton Amy · CIK 0001371523 · VP, Chief Accounting Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 135,564 F1 · shares: These shares were sold upon the vesting of Restricted Stock Units to pay tax withholding obligations. The sale was to satisfy tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary transaction. This amendment is being filed to address an administrative error in reporting the number of shares sold in the sell to cover transaction on December 6, 2024. The original Form 4 reported that 4,329 shares were sold, when in fact, 4,425 shares were sold. F2 · balance_after: As a result of the administrative error in reporting the number of shares sold in the sell to cover transaction on December 6, 2024, the number of shares reported as beneficially owned in this amendment reflects a decrease in the number of shares reported as beneficially owned in the original Form 4. Read SEC document |
| December 04, 2024 Filed Dec 4, 2024 21:11 UTC |
GREEN ANDREW MVP Regulatory
|
SaleCommon Stock | 7,618 | $30.00 | $228,540.00 |
DisclosureSEC source: 0000784199-24-000245 · wk-form4_1733346705.xml · nonDerivative · entry 1 GREEN ANDREW M · CIK 0001191000 · VP Regulatory 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 33,503 F1 · shares: The sale reported on this form was effected pursuant to a 10b5-1 trading plan adopted by the reporting person on August 13, 2024. F2 · price: Reflects the price the shares were sold. Read SEC document |
| October 01, 2024 Filed Oct 2, 2024 22:44 UTC |
Horton AmyVP, Chief Accounting Officer
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 12,430 | $0.00 Strike: $21.55 | $0.00 |
DisclosureSEC source: 0000784199-24-000231 · wk-form4_1727909080.xml · derivative · entry 3 Horton Amy · CIK 0001371523 · VP, Chief Accounting Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 12,430 shares Expires 2025-03-12 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: Stock option vests 33 1/3% per year beginning on the first anniversary of the grant date. The first exercisable date was March 12, 2019. Read SEC document |
| October 01, 2024 Filed Oct 2, 2024 22:44 UTC |
Horton AmyVP, Chief Accounting Officer
|
SaleCommon Stock | 12,430 | $26.18 | $325,414.91 |
DisclosureSEC source: 0000784199-24-000231 · wk-form4_1727909080.xml · nonDerivative · entry 2 Horton Amy · CIK 0001371523 · VP, Chief Accounting Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 139,989 F1 · shares: The sale reported on this form was effected pursuant to a 10b5-1 trading plan adopted by the reporting person on March 11, 2024. F2 · price: Reflects weighted average price. Range of prices were between $26.00 to $26.62. The reporting person will provide upon request by the Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price. Read SEC document |
| October 01, 2024 Filed Oct 2, 2024 22:44 UTC |
Horton AmyVP, Chief Accounting Officer
|
Exercise / conversionCommon Stock | 12,430 | $21.55 | $267,866.50 |
DisclosureSEC source: 0000784199-24-000231 · wk-form4_1727909080.xml · nonDerivative · entry 1 Horton Amy · CIK 0001371523 · VP, Chief Accounting Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 152,419 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: The sale reported on this form was effected pursuant to a 10b5-1 trading plan adopted by the reporting person on March 11, 2024. Read SEC document |
| August 26, 2024 Filed Aug 27, 2024 20:47 UTC |
Holloway Jean FSVP, General Counsel
|
SaleCommon Stock | 3,167 | $26.55 | $84,095.88 |
DisclosureSEC source: 0000784199-24-000224 · wk-form4_1724791614.xml · nonDerivative · entry 1 Holloway Jean F · CIK 0001540065 · SVP, General Counsel 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 161,932 F1 · price: Reflects weighted average price for Restricted Stock Awards. Range of prices were between $26.55 to $26.61. The reporting person will provide upon request by the Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price. Read SEC document |
| August 16, 2024 Filed Aug 19, 2024 20:58 UTC |
Getz Matthew AVP, Human Resources
|
SaleCommon Stock | 2,562 | $25.31 | $64,848.06 |
DisclosureSEC source: 0000784199-24-000222 · wk-form4_1724101102.xml · nonDerivative · entry 2 Getz Matthew A · CIK 0001784253 · VP, Human Resources 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 34,116 F2 · price: Reflects weighted average price for Restricted Stock Units. Range of prices were between $25.30 to $25.34. The reporting person will provide upon request by the Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price. Read SEC document |
| August 16, 2024 Filed Aug 19, 2024 20:58 UTC |
Getz Matthew AVP, Human Resources
|
SaleCommon Stock | 6,858 | $25.31 | $173,586.27 |
DisclosureSEC source: 0000784199-24-000222 · wk-form4_1724101102.xml · nonDerivative · entry 1 Getz Matthew A · CIK 0001784253 · VP, Human Resources 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 36,678 F1 · price: Reflects weighted average price for Performance Stock Units. Range of prices were between $25.30 to $25.34. The reporting person will provide upon request by the Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price. Read SEC document |
| August 15, 2024 Filed Aug 16, 2024 15:38 UTC |
Holloway Jean FSVP, General Counsel
|
SaleCommon Stock | 2,383 | $25.76 | $61,392.99 |
DisclosureSEC source: 0000784199-24-000220 · wk-form4_1723822725.xml · nonDerivative · entry 1 Holloway Jean F · CIK 0001540065 · SVP, General Counsel 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 165,099 F1 · price: Reflects the price the shares were sold. Read SEC document |
| August 13, 2024 Filed Aug 15, 2024 14:37 UTC |
SEMEDO ANTHONY B.Director
|
SaleCommon Stock | 9,709 | $24.99 | $242,627.91 |
DisclosureSEC source: 0000784199-24-000218 · wk-form4_1723732622.xml · nonDerivative · entry 1 SEMEDO ANTHONY B. · CIK 0001886324 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 34,159 F1 · price: Reflects the price the shares were sold. Read SEC document |
| June 30, 2024 Filed Jan 30, 2025 15:13 UTC |
Stanton Marshall S.SVP, Clinical & MD Affair
|
GrantCommon Stock | 855 | $15.20 | $12,996.00 |
DisclosureSEC source: 0000784199-25-000004 · wk-form5_1738249991.xml · nonDerivative · entry 1 Stanton Marshall S. · CIK 0001849615 · SVP, Clinical & MD Affair 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 84,151 F1 · price: These shares were acquired pursuant to Artivion Inc.'s Employee Stock Purchase Plan (ESPP). The shares were acquired in transactions exempt pursuant to 16b-3. Read SEC document |
| June 30, 2024 Filed Jan 30, 2025 15:16 UTC |
Davis John EChief Commercial Officer
|
GrantCommon Stock | 1,398 | $15.20 | $21,249.60 |
DisclosureSEC source: 0000784199-25-000006 · wk-form5_1738250165.xml · nonDerivative · entry 1 Davis John E · CIK 0001653206 · Chief Commercial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 167,088 F1 · price: These shares were acquired pursuant to Artivion Inc.'s Employee Stock Purchase Plan (ESPP). The shares were acquired in transactions exempt pursuant to 16b-3. Read SEC document |
| June 30, 2024 Filed Jan 30, 2025 15:09 UTC |
Holloway Jean FSVP, General Counsel
|
GrantCommon Stock | 977 | $15.20 | $14,850.40 |
DisclosureSEC source: 0000784199-25-000002 · wk-form5_1738249772.xml · nonDerivative · entry 1 Holloway Jean F · CIK 0001540065 · SVP, General Counsel 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 154,839 F1 · price: These shares were acquired pursuant to Artivion Inc.'s Employee Stock Purchase Plan (ESPP). The shares were acquired in transactions exempt pursuant to 16b-3. Read SEC document |
| May 30, 2024 Filed Jun 3, 2024 12:44 UTC |
ACKERMAN THOMAS FDirector
|
GrantCommon Stock | 6,289 | $0.00 | $0.00 |
DisclosureSEC source: 0000784199-24-000203 · wk-form4_1717418645.xml · nonDerivative · entry 1 ACKERMAN THOMAS F · CIK 0001141720 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 143,571 F1 · shares: RSA Grant vests on May 30th 2025, pursuant to the terms of the Equity and Cash Incentive Plan. Read SEC document |
| May 30, 2024 Filed Jun 3, 2024 12:41 UTC |
BEVEVINO DANIEL JDirector
|
GrantCommon Stock | 6,289 | $0.00 | $0.00 |
DisclosureSEC source: 0000784199-24-000201 · wk-form4_1717418454.xml · nonDerivative · entry 1 BEVEVINO DANIEL J · CIK 0001186458 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 143,736 F1 · shares: RSA Grant vests on May 30th 2025, pursuant to the terms of the Equity and Cash Incentive Plan. Read SEC document |
| May 30, 2024 Filed Jun 3, 2024 12:38 UTC |
Salveson Jon WDirector
|
GrantCommon Stock | 6,289 | $0.00 | $0.00 |
DisclosureSEC source: 0000784199-24-000199 · wk-form4_1717418330.xml · nonDerivative · entry 1 Salveson Jon W · CIK 0001372026 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 123,515 F1 · shares: RSA Grant vests on May 30th 2025, pursuant to the terms of the Equity and Cash Incentive Plan. Read SEC document |
| May 30, 2024 Filed Jun 3, 2024 12:36 UTC |
Bullock JamesDirector
|
GrantCommon Stock | 6,289 | $0.00 | $0.00 |
DisclosureSEC source: 0000784199-24-000197 · wk-form4_1717418172.xml · nonDerivative · entry 1 Bullock James · CIK 0001172340 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 62,322 F1 · shares: RSA Grant vests on May 30th 2025, pursuant to the terms of the Equity and Cash Incentive Plan. Read SEC document |
| May 30, 2024 Filed Jun 3, 2024 12:33 UTC |
Burbank Jeffrey HDirector
|
GrantCommon Stock | 6,289 | $0.00 | $0.00 |
DisclosureSEC source: 0000784199-24-000195 · wk-form4_1717417977.xml · nonDerivative · entry 1 Burbank Jeffrey H · CIK 0001341411 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 47,471 F1 · shares: RSA Grant vests on May 30th 2025, pursuant to the terms of the Equity and Cash Incentive Plan. Read SEC document |
| May 30, 2024 Filed Jun 3, 2024 12:29 UTC |
Borgstrom Marna PDirector
|
GrantCommon Stock | 6,289 | $0.00 | $0.00 |
DisclosureSEC source: 0000784199-24-000193 · wk-form4_1717417776.xml · nonDerivative · entry 1 Borgstrom Marna P · CIK 0001744267 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 42,763 F1 · shares: RSA Grant vests on May 30th 2025, pursuant to the terms of the Equity and Cash Incentive Plan. Read SEC document |
| May 30, 2024 Filed Jun 3, 2024 12:24 UTC |
SEMEDO ANTHONY B.Director
|
GrantCommon Stock | 6,289 | $0.00 | $0.00 |
DisclosureSEC source: 0000784199-24-000191 · wk-form4_1717417489.xml · nonDerivative · entry 1 SEMEDO ANTHONY B. · CIK 0001886324 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 43,868 F1 · shares: RSA Grant vests on May 30th 2025, pursuant to the terms of the Equity and Cash Incentive Plan. Read SEC document |
| May 30, 2024 Filed Jun 3, 2024 12:22 UTC |
Hoff Elizabeth ADirector
|
GrantCommon Stock | 6,289 | $0.00 | $0.00 |
DisclosureSEC source: 0000784199-24-000189 · wk-form4_1717417360.xml · nonDerivative · entry 1 Hoff Elizabeth A · CIK 0001949762 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 25,064 F1 · shares: RSA Grant vests on May 30th 2025, pursuant to the terms of the Equity and Cash Incentive Plan. Read SEC document |
| May 10, 2024 Filed May 13, 2024 22:05 UTC |
Holloway Jean FSVP, General Counsel
|
SaleCommon Stock | 1,250 | $23.42 | $29,275.13 |
DisclosureSEC source: 0000784199-24-000176 · wk-form4_1715637944.xml · nonDerivative · entry 1 Holloway Jean F · CIK 0001540065 · SVP, General Counsel 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 167,482 F1 · price: Reflects the price the shares were sold. Read SEC document |
| May 09, 2024 Filed May 10, 2024 21:12 UTC |
Holloway Jean FSVP, General Counsel
|
SaleCommon Stock | 979 | $23.79 | $23,285.52 |
DisclosureSEC source: 0000784199-24-000174 · wk-form4_1715375556.xml · nonDerivative · entry 1 Holloway Jean F · CIK 0001540065 · SVP, General Counsel 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 168,732 F1 · price: Reflects the price the shares were sold. Read SEC document |
| March 20, 2024 Filed Mar 21, 2024 21:14 UTC |
Stanton Marshall S.SVP, Clinical & MD Affair
|
SaleCommon Stock | 2,183 | $20.39 | $44,511.37 |
DisclosureSEC source: 0000784199-24-000164 · wk-form4_1711055634.xml · nonDerivative · entry 1 Stanton Marshall S. · CIK 0001849615 · SVP, Clinical & MD Affair 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 83,296 F1 · shares: These shares were sold upon the vesting of Restricted Stock awards to pay tax withholding obligations. The sale was to satisfy tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary transaction. Read SEC document |
| March 15, 2024 Filed Mar 18, 2024 22:09 UTC |
GREEN ANDREW MVP Regulatory
|
SaleCommon Stock | 1,462 | $20.00 | $29,240.00 |
DisclosureSEC source: 0000784199-24-000162 · wk-form4_1710799753.xml · nonDerivative · entry 1 GREEN ANDREW M · CIK 0001191000 · VP Regulatory 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 41,121 F1 · shares: The sale reported on this form was effected pursuant to a 10b5-1 trading plan adopted by the reporting person on December 14, 2023. F2 · price: Reflects the price the shares were sold. Read SEC document |
| March 14, 2024 Filed Mar 15, 2024 21:20 UTC |
GREEN ANDREW MVP Regulatory
|
SaleCommon Stock | 3,994 | $20.00 | $79,880.00 |
DisclosureSEC source: 0000784199-24-000160 · wk-form4_1710537608.xml · nonDerivative · entry 1 GREEN ANDREW M · CIK 0001191000 · VP Regulatory 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 42,583 F1 · shares: The sale reported on this form was effected pursuant to a 10b5-1 trading plan adopted by the reporting person on December 14, 2023. F2 · price: Reflects the price the shares were sold. Read SEC document |
| March 12, 2024 Filed Mar 15, 2024 01:06 UTC |
Getz Matthew AVP, Human Resources
|
SaleCommon Stock | 5,000 | $19.94 | $99,719.50 |
DisclosureSEC source: 0000784199-24-000158 · wk-form4_1710464762.xml · nonDerivative · entry 1 Getz Matthew A · CIK 0001784253 · VP, Human Resources 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 43,536 F1 · price: Reflects weighted average price. Range of prices were between $19.90 to $20.015. The reporting person will provide upon request by the Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price Read SEC document |
| March 05, 2024 Filed Mar 7, 2024 23:20 UTC |
Mackin James PPresident & CEO
|
SaleCommon Stock | 13,996 | $18.72 | $262,037.31 |
DisclosureSEC source: 0000784199-24-000108 · wk-form4_1709853614.xml · nonDerivative · entry 2 Mackin James P · CIK 0001408470 · President & CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 705,562 F2 · shares: These shares were sold upon the vesting of performance stock units to pay tax withholding obligations. The sale was to satisfy tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary transaction. Read SEC document |
| March 05, 2024 Filed Mar 7, 2024 23:16 UTC |
Holloway Jean FSVP, General Counsel
|
SaleCommon Stock | 2,380 | $18.72 | $44,558.84 |
DisclosureSEC source: 0000784199-24-000106 · wk-form4_1709853394.xml · nonDerivative · entry 2 Holloway Jean F · CIK 0001540065 · SVP, General Counsel 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 169,669 F2 · shares: These shares were sold upon the vesting of performance stock units to pay tax withholding obligations. The sale was to satisfy tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary transaction. Read SEC document |
| March 05, 2024 Filed Mar 7, 2024 23:14 UTC |
Davis John EChief Commercial Officer
|
SaleCommon Stock | 2,022 | $18.72 | $37,856.29 |
DisclosureSEC source: 0000784199-24-000104 · wk-form4_1709853255.xml · nonDerivative · entry 2 Davis John E · CIK 0001653206 · Chief Commercial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 165,637 F2 · shares: These shares were sold upon the vesting of performance stock units to pay tax withholding obligations. The sale was to satisfy tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary transaction. Read SEC document |
| March 05, 2024 Filed Mar 7, 2024 23:12 UTC |
Getz Matthew AVP, Human Resources
|
SaleCommon Stock | 1,157 | $18.72 | $21,661.35 |
DisclosureSEC source: 0000784199-24-000102 · wk-form4_1709853116.xml · nonDerivative · entry 2 Getz Matthew A · CIK 0001784253 · VP, Human Resources 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 48,503 F2 · shares: These shares were sold upon the vesting of performance stock units to pay tax withholding obligations. The sale was to satisfy tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary transaction. Read SEC document |
| March 05, 2024 Filed Mar 7, 2024 23:10 UTC |
Maney Rochelle L.VP, Quality
|
SaleCommon Stock | 1,157 | $18.72 | $21,661.82 |
DisclosureSEC source: 0000784199-24-000100 · wk-form4_1709852994.xml · nonDerivative · entry 2 Maney Rochelle L. · CIK 0001850597 · VP, Quality 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 46,536 F2 · shares: These shares were sold upon the vesting of performance stock units to pay tax withholding obligations. The sale was to satisfy tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary transaction. Read SEC document |
| March 05, 2024 Filed Mar 7, 2024 23:07 UTC |
GREEN ANDREW MVP Regulatory
|
SaleCommon Stock | 1,160 | $18.72 | $21,717.64 |
DisclosureSEC source: 0000784199-24-000098 · wk-form4_1709852827.xml · nonDerivative · entry 2 GREEN ANDREW M · CIK 0001191000 · VP Regulatory 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 46,541 F2 · shares: 2. These shares were sold upon the vesting of performance stock units to pay tax withholding obligations. The sale was to satisfy tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary transaction. Read SEC document |
| March 05, 2024 Filed Mar 7, 2024 23:05 UTC |
Stanton Marshall S.SVP, Clinical & MD Affair
|
SaleCommon Stock | 1,506 | $18.72 | $28,195.48 |
DisclosureSEC source: 0000784199-24-000096 · wk-form4_1709852706.xml · nonDerivative · entry 2 Stanton Marshall S. · CIK 0001849615 · SVP, Clinical & MD Affair 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 85,438 F2 · shares: These shares were sold upon the vesting of performance stock units to pay tax withholding obligations. The sale was to satisfy tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary transaction. Read SEC document |
| March 05, 2024 Filed Mar 7, 2024 23:01 UTC |
Horton AmyVP, Chief Accounting Officer
|
SaleCommon Stock | 1,152 | $18.72 | $21,568.09 |
DisclosureSEC source: 0000784199-24-000094 · wk-form4_1709852505.xml · nonDerivative · entry 2 Horton Amy · CIK 0001371523 · VP, Chief Accounting Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 139,957 F2 · shares: These shares were sold upon the vesting of performance stock units to pay tax withholding obligations. The sale was to satisfy tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary transaction. Read SEC document |
| March 05, 2024 Filed Mar 15, 2024 00:09 UTC Amendment |
Horton AmyVP, Chief Accounting Officer
|
SaleCommon Stock | 1,152 | $18.72 | $21,568.09 |
DisclosureSEC source: 0000784199-24-000130 · wk-form4a_1710461384.xml · nonDerivative · entry 2 Horton Amy · CIK 0001371523 · VP, Chief Accounting Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 139,989 F3 · shares: These shares were sold upon the vesting of performance stock units to pay tax withholding obligations. The sale was to satisfy tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary transaction. F2 · balance_after: As a result of the administrative error in reporting the number of shares sold in the sell to cover transactions on February 26, 2024, the number of shares reported as beneficially owned in this amendment reflects an increase in the number of shares reported as beneficially owned in the original Form 4. Read SEC document |
| March 05, 2024 Filed Mar 15, 2024 00:00 UTC Amendment |
Maney Rochelle L.VP, Quality
|
SaleCommon Stock | 1,157 | $18.72 | $21,661.82 |
DisclosureSEC source: 0000784199-24-000122 · wk-form4a_1710460808.xml · nonDerivative · entry 2 Maney Rochelle L. · CIK 0001850597 · VP, Quality 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 46,569 F3 · shares: These shares were sold upon the vesting of performance stock units to pay tax withholding obligations. The sale was to satisfy tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary transaction. F2 · balance_after: As a result of the administrative error in reporting the number of shares sold in the sell to cover transactions on February 26, 2024, the number of shares reported as beneficially owned in this amendment reflects an increase in the number of shares reported as beneficially owned in the original Form 4. Read SEC document |
| March 05, 2024 Filed Mar 14, 2024 23:55 UTC Amendment |
Holloway Jean FSVP, General Counsel
|
SaleCommon Stock | 2,380 | $18.72 | $44,558.84 |
DisclosureSEC source: 0000784199-24-000118 · wk-form4a_1710460531.xml · nonDerivative · entry 2 Holloway Jean F · CIK 0001540065 · SVP, General Counsel 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 169,711 F3 · shares: These shares were sold upon the vesting of performance stock units to pay tax withholding obligations. The sale was to satisfy tax withholding obligations to be funded by a sell to cover transaction and does not represent a discretionary transaction. F2 · balance_after: As a result of the administrative error in reporting the number of shares sold in the sell to cover transactions on February 26, 2024, the number of shares reported as beneficially owned in this amendment reflects an increase in the number of shares reported as beneficially owned in the original Form 4. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.